Acrivon Therapeutics ACRV
NASDAQ ACRV
$2.01 -0.04 (-1.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Acrivon Therapeutics (ACRV) Other Operating Expenses (2021 - 2022)

Updated

Acrivon Therapeutics' Other Operating Expenses came in at -$8.5 million for Q4 2022, compared with $4.27 million a year earlier.

Analysis

Acrivon Therapeutics (ACRV) Other Operating Expenses (2021 - 2022) Analysis & Trends

For FY2021, Acrivon Therapeutics' Other Operating Expenses was $10.68 million.

  • Business Quant data shows ACRV's Other Operating Expenses at $9.58 million (Q3 2022), $5.93 million (Q2 2022) and $7.21 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Acrivon Therapeutics 87.84 Mn 87.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -8.50 Mn
Sep 30, 2022 9.58 Mn
Jun 30, 2022 5.93 Mn
Mar 31, 2022 7.21 Mn
Dec 31, 2021 4.27 Mn
Sep 30, 2021 2.67 Mn
API Access

Acrivon Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ACRV&period=max&api_key=YOUR_API_KEY